New Mass Spectrometry Series Enhances Analytical Diagnostics
By LabMedica International staff writers Posted on 12 Aug 2014 |
Image: The new Triple Quad 4500MD, along with the new QTRAP 4500MD, LC/MS/MS systems now provide analytic clinical diagnostics with flexibility, exceptional sensitivity, and faster data acquisition (Photo courtesy of AB SCIEX).
A leading mass spectrometry portfolio for analytic clinical testing has been expanded with a new series offering flexibility, exceptional sensitivity, and faster data acquisition.
SCIEX Diagnostics (Framingham, MA, USA), part of AB SCIEX, unveiled its latest products—theTriple Quad 4500MD and QTRAP 4500MD LC/MS/MS systems—at the American Association of Clinical Chemistry (AACC) Annual Meeting and Expo in Chicago, Illinois, July 29–31, 2014. Expected to be available in the US and select EU countries in September 2014, the 4500MD series joins the company's growing family of in vitro diagnostic devices, including the 3200MD and IVD-MS Analyzer systems launched in 2013, as well as a series of kits for vitamin D, immunosuppressants, and newborn screening testing to be available in August 2014 for use in certain European countries.
The new 4500MD series offers exceptional sensitivity and faster data acquisition over previous systems, providing reliable results so physicians and patients have accurate answers quickly. It is a flexible LC/MS/MS platform that offers enhanced performance to enable customers developing their own applications to validate methods that require lower detection limits or higher throughput, with the peace of mind afforded by a regulatory compliant solution.
"As scientific understanding progressively evolves into improved clinical diagnostic testing, diagnostic customers who develop their own assays are turning to fast, sensitive instruments to perform routine tests with high efficiency and cost savings," said Chris Radloff, vice president of Applied Markets and Clinical Research at AB SCIEX, "By bringing the power, flexibility, reliability, and accuracy of our mass spectrometry technology to clinical testing laboratories, AB SCIEX is enabling customers to deliver high quality diagnostic information to clinicians who make decisions affecting patient care."
Related Links:
SCIEX Diagnostics
AB SCIEX
SCIEX Diagnostics (Framingham, MA, USA), part of AB SCIEX, unveiled its latest products—theTriple Quad 4500MD and QTRAP 4500MD LC/MS/MS systems—at the American Association of Clinical Chemistry (AACC) Annual Meeting and Expo in Chicago, Illinois, July 29–31, 2014. Expected to be available in the US and select EU countries in September 2014, the 4500MD series joins the company's growing family of in vitro diagnostic devices, including the 3200MD and IVD-MS Analyzer systems launched in 2013, as well as a series of kits for vitamin D, immunosuppressants, and newborn screening testing to be available in August 2014 for use in certain European countries.
The new 4500MD series offers exceptional sensitivity and faster data acquisition over previous systems, providing reliable results so physicians and patients have accurate answers quickly. It is a flexible LC/MS/MS platform that offers enhanced performance to enable customers developing their own applications to validate methods that require lower detection limits or higher throughput, with the peace of mind afforded by a regulatory compliant solution.
"As scientific understanding progressively evolves into improved clinical diagnostic testing, diagnostic customers who develop their own assays are turning to fast, sensitive instruments to perform routine tests with high efficiency and cost savings," said Chris Radloff, vice president of Applied Markets and Clinical Research at AB SCIEX, "By bringing the power, flexibility, reliability, and accuracy of our mass spectrometry technology to clinical testing laboratories, AB SCIEX is enabling customers to deliver high quality diagnostic information to clinicians who make decisions affecting patient care."
Related Links:
SCIEX Diagnostics
AB SCIEX
Latest Clinical Chem. News
- 3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
- POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
- Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
- New Blood Testing Method Detects Potent Opioids in Under Three Minutes
- Wireless Hepatitis B Test Kit Completes Screening and Data Collection in One Step
- Pain-Free, Low-Cost, Sensitive, Radiation-Free Device Detects Breast Cancer in Urine
- Spit Test Detects Breast Cancer in Five Seconds
- Electrochemical Sensors with Next-Generation Coating Advances Precision Diagnostics at POC
- First-Of-Its-Kind Handheld Device Accurately Detects Fentanyl in Urine within Seconds
- New Fluorescent Sensor Array Lights up Alzheimer’s-Related Proteins for Earlier Detection
- Automated Mass Spectrometry-Based Clinical Analyzer Could Transform Lab Testing
- Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses
- Non-Invasive Sensor Monitors Changes in Saliva Compositions to Rapidly Diagnose Diabetes
- Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia
- Urine Test for Monitoring Changes in Kidney Health Markers Can Predict New-Onset Heart Failure
- AACC Releases Comprehensive Diabetes Testing Guidelines